[Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti–CTLA-4 antibody in a mouse model

• Tomomi Nakayama Iwata,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Oncology Research Laboratories I, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan

  ⨯
• Kiyoshi Sugihara,

  Roles Supervision, Writing – review & editing

  Affiliation Oncology Research Laboratories I, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan

  ⨯
• Teiji Wada ,

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: wada.teiji.fv@daiichisankyo.co.jp

  Affiliation Oncology Research Laboratories I, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan

  http://orcid.org/0000-0002-1565-0730

  ⨯
• Toshinori Agatsuma

  Roles Writing – review & editing

  Affiliation Oncology Research Laboratories I, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan

  ⨯